136 related articles for article (PubMed ID: 11563689)
1. Common conformational effects of p53 mutations.
Chen JM; Rosal R; Smith S; Pincus MR; Brandt-Rauf PW
J Protein Chem; 2001 Feb; 20(2):101-5. PubMed ID: 11563689
[TBL] [Abstract][Full Text] [Related]
2. Common conformational effects in the p53 protein of vinyl chloride-induced mutations.
Chen JM; Smith SJ; Marion MJ; Pincus MR; Brandt-Rauf PW
J Protein Chem; 1999 May; 18(4):467-72. PubMed ID: 10449043
[TBL] [Abstract][Full Text] [Related]
3. Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.
Brandt-Rauf PW; Chen JM; Marion MJ; Smith SJ; Luo JC; Carney W; Pincus MR
J Protein Chem; 1996 May; 15(4):367-75. PubMed ID: 8819013
[TBL] [Abstract][Full Text] [Related]
4. Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.
Brandt-Rauf PW; Monaco R; Pincus MR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9262-6. PubMed ID: 7937752
[TBL] [Abstract][Full Text] [Related]
5. Conformational effects of selected cancer-related amino acid substitutions in the p53 protein.
Brandt-Rauf PW; De Vivo I; Dykes DC; Pincus MR
J Biomol Struct Dyn; 1992 Oct; 10(2):253-64. PubMed ID: 1466808
[TBL] [Abstract][Full Text] [Related]
6. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
Legros Y; Meyer A; Ory K; Soussi T
Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
8. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
Pavletich NP; Chambers KA; Pabo CO
Genes Dev; 1993 Dec; 7(12B):2556-64. PubMed ID: 8276238
[TBL] [Abstract][Full Text] [Related]
9. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
10. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.
Halazonetis TD; Kandil AN
EMBO J; 1993 Dec; 12(13):5057-64. PubMed ID: 8262048
[TBL] [Abstract][Full Text] [Related]
11. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the p53 core domain L1 loop.
Zupnick A; Prives C
J Biol Chem; 2006 Jul; 281(29):20464-73. PubMed ID: 16687402
[TBL] [Abstract][Full Text] [Related]
13. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.
Wallentine BD; Wang Y; Tretyachenko-Ladokhina V; Tan M; Senear DF; Luecke H
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2146-56. PubMed ID: 24100332
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
Cho Y; Gorina S; Jeffrey PD; Pavletich NP
Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
[TBL] [Abstract][Full Text] [Related]
15. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
[TBL] [Abstract][Full Text] [Related]
16. Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library.
Shiraishi K; Kato S; Han SY; Liu W; Otsuka K; Sakayori M; Ishida T; Takeda M; Kanamaru R; Ohuchi N; Ishioka C
J Biol Chem; 2004 Jan; 279(1):348-55. PubMed ID: 14559903
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
[TBL] [Abstract][Full Text] [Related]
18. The substitutions G245C and G245D in the Zn(2+)-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain.
Pintus SS; Ivanisenko NV; Demenkov PS; Ivanisenko TV; Ramachandran S; Kolchanov NA; Ivanisenko VA
J Biomol Struct Dyn; 2013; 31(1):78-86. PubMed ID: 22803791
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive alanine scanning mutagenesis of the Escherichia coli transcriptional activator SoxS: identifying amino acids important for DNA binding and transcription activation.
Griffith KL; Wolf RE
J Mol Biol; 2002 Sep; 322(2):237-57. PubMed ID: 12217688
[TBL] [Abstract][Full Text] [Related]
20. Structure-based rescue of common tumor-derived p53 mutants.
Wieczorek AM; Waterman JL; Waterman MJ; Halazonetis TD
Nat Med; 1996 Oct; 2(10):1143-6. PubMed ID: 8837616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
